山東赫達(002810.SZ):放棄米特加(上海)股權轉讓的優先購買權
格隆匯 3 月 16日丨山東赫達(002810.SZ)公佈,2021年3月16日,公司第八屆董事會第十一次會議,審議通過了《關於放棄參股子公司股權轉讓優先購買權的議案》。
米特加(上海)食品科技有限公司(“米特加(上海)”、“標的公司”)系公司的參股子公司,註冊資本為5000萬元,公司持有其30%股權。
公司近期獲悉,米特加(上海)控股股東高起擬將其持有的米特加(上海)10%股權(“標的股權”)轉讓給自然人張曉敏。根據《公司法》、《米特加(上海)食品科技有限公司章程》等有關規定,公司對上述標的股權享有在同等條件下的優先購買權。為加快植物蛋白人造肉產品研發及投放市場速度,推動米特加(上海)快速發展,助力公司食品級纖維素醚在食品領域的可持續發展,經綜合考慮,公司同意放棄上述標的股權轉讓的優先購買權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.